Multiple doses of pegylated long-acting growth hormone are well tolerated in healthy male volunteers and possess a potential once-weekly treatment profile.
- DOI
- 10.1111/j.1365-2265.2010.03863.x
- Published
- 2010 Dec
- Container
- Clinical endocrinology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/j.1365-2265.2010.03863.x,
title = {Multiple doses of pegylated long-acting growth hormone are well tolerated in healthy male volunteers and possess a potential once-weekly treatment profile.},
author = {Rasmussen MH and Jensen L and Anderson TW and Klitgaard T and Madsen J},
year = {2010},
journal = {Clinical endocrinology},
doi = {10.1111/j.1365-2265.2010.03863.x},
url = {https://doi.org/10.1111/j.1365-2265.2010.03863.x}
}RIS
TY - JOUR TI - Multiple doses of pegylated long-acting growth hormone are well tolerated in healthy male volunteers and possess a potential once-weekly treatment profile. AU - Rasmussen MH AU - Jensen L AU - Anderson TW AU - Klitgaard T AU - Madsen J PY - 2010 JO - Clinical endocrinology DO - 10.1111/j.1365-2265.2010.03863.x UR - https://doi.org/10.1111/j.1365-2265.2010.03863.x ER -
APA
MH, R., L, J., TW, A., T, K., & J, M. (2010). Multiple doses of pegylated long-acting growth hormone are well tolerated in healthy male volunteers and possess a potential once-weekly treatment profile.. Clinical endocrinology. https://doi.org/10.1111/j.1365-2265.2010.03863.x
Source records
- pubmed · retrieved 2026-11-10T13:12:33.141Z